ASSIP, Attempted Suicide Short Intervention Program. Two Year Follow-Up Study (ASSIP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02505373 |
Recruitment Status :
Completed
First Posted : July 22, 2015
Last Update Posted : January 14, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Objective
Attempted suicide is the main risk factor for repeated suicidal behavior. However, evidence of the effectiveness of follow-up treatments for these patients is limited. The authors evaluated the effectiveness of the Attempted Suicide Short Intervention Program (ASSIP), a novel brief therapy based on a patient-oriented model of suicidal behavior. The ASSIP consists of three sessions followed by regular letters for 24 months.
Method
In this treatment study, 120 patients were randomly assigned to either the ASSIP intervention or a control group that received a one-session clinical assessment. Both groups received in- and outpatient treatment as usual. Study participants also completed a set of psychosocial and clinical questionnaires every 6 months during a 24-month follow-up period.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Suicide Attempt Suicide Suicidal Ideation | Behavioral: Attempted Suicide Short Intervention Program (ASSIP) Behavioral: Control Group (CG) | Not Applicable |
Background
In the prevention and treatment of suicidality the main emphasis according to the traditional medical model has been on diagnosis and treatment of mental disorders, first and foremost depression. However, it is debatable how far this approach toward the suicidal patient can actually affect suicide rates. It has been argued that the mechanisms of suicidal behavior should be studied independently of any associated psychiatric disorder.
Follow-up studies strongly suggest that when a person has attempted suicide, the risk of future suicidal behavior, including death by suicide, cannot be "cured". Once a person has tried to solve an emotional crisis with a suicide attempt, this behavioral pattern will quickly re-emerge in similar situations in the future, not only because a suicide attempt provides a - temporary - solution, but also because very often it associated with an immediate sense of relief. The prevailing view emerging from recent developments in suicide research is that, following attempted suicide, it is crucial to establish individual safety strategies with patients for coping differently in future emotional crises. For as many patients as possible to benefit, treatments targeting suicidality should be brief and focused, and, of course, effective.
ASSIP combines aspects of action theory, cognitive behavior therapy, and attachment theory. A fundamental assumption is that an action theoretical approach toward the suicidal patient will establish a therapeutic alliance in the sense of a "secure base", which will enhance the effect of the regular letters following the four treatment sessions. ASSIP is not a stand-alone therapy but should be offered to suicidal patients in addition to the usual clinical management and follow-up treatment.
Objective
-
How effective is ASSIP, compared to a control group in preventing suicidal behaviour after a suicide attempt?
- Primary outcome measures: Suicidal behaviour, suicidal ideation
- Secondary outcome measures: Depression, coping skills, contact to health care system
-
Which parameters have a moderating influence on outcome measures?
- Therapeutic alliance
- Diagnosis
- Previous suicide attempts
Methods
In this treatment study, 120 patients were randomly assigned to either the ASSIP intervention or a control group that received a one-session clinical assessment. Both groups received in- and outpatient treatment as usual. The quality of the therapeutic alliance as a moderating factor for outcome was measured at the therapy sessions 1 (both groups) and 3 (ASSIP group only) using the Helping Alliance Questionnaire (HAq). Regarding outcome measures the study participants completed a set of psychosocial and clinical questionnaires every 6 months during a 24-months follow-up period.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 120 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | A Novel Brief Therapy for Attempted Suicide: Two Year Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP) |
Study Start Date : | January 2009 |
Actual Primary Completion Date : | June 2014 |
Actual Study Completion Date : | June 2014 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention Group ASSIP
Intervention Group ASSIP (Brief Therapy)
|
Behavioral: Attempted Suicide Short Intervention Program (ASSIP)
The brief therapy ASSIP consists of three to four sessions, which are ideally administered within a period of 2 to 4 weeks. Therapy sessions are scheduled for 60 to 90 minutes. Session 1: A narrative interview is conducted, in which the patient is asked to tell his or her personal story which led to the suicidal crisis. The narrative is video-recorded. Session 2: Using video-playback of the recorded narrative, patient and therapist explore further details of the suicidal process. Session 3: A case conceptualization focusing on the patient's vulnerability and the trigger of the suicidal crisis is formulated in writing. A list of safety strategies for the prevention of future suicidal behaviour is developed jointly with the patient. Regular letters are sent to patients over a period of 2 years. |
Active Comparator: Control Group CG
Control Group CG (structured interview)
|
Behavioral: Control Group (CG)
Participants assigned to the control group underwent a single clinical interview that included a structured assessment of suicide using the SSF (Jobes, 2006). |
- Suicidal behaviour [ Time Frame: 2-year follow-up ]Measured by socio-demographic & clinical questionnaire
- Suicidal behaviour [ Time Frame: 1-year follow-up ]Measured by socio-demographic & clinical questionnaire
- Contact to health care system [ Time Frame: At baseline, after 6 months, after 12 months, after 18 months, after 24 months ]Measured by questionnaire
- Suicidal ideation [ Time Frame: At baseline, after 6 months, after 12 months, after 18 months, after 24 months ]Measured by Beck Scale for Suicidal Ideation (BSS)
- Depression [ Time Frame: At baseline, after 6 months, after 12 months, after 18 months, after 24 months ]Measured by Beck Depression Inventory (BDI)
- Coping [ Time Frame: At baseline, after 6 months, after 12 months, after 18 months, after 24 months ]Measured by Brief COPE
- Global distress [ Time Frame: At baseline, after 6 months, after 12 months, after 18 months, after 24 months ]Measured by SCL-9

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Male/female
- Inpatient/outpatient, day care treatment
- German language
- All diagnosis (except: psychosis)
- Written informed consent
Exclusion Criteria
- Psychosis
- Imprisonment
- Foreign languages

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02505373
Switzerland | |
University Hospital of Psychiatry and Psychotherapy, University of Bern | |
Bern, Switzerland, 3008 |
Principal Investigator: | Konrad Michel, Prof. | Hospital of Psychiatry and Psychotherapy, University of Bern | |
Principal Investigator: | Anja C Gysin-Maillart, Ph.D. | Hospital of Psychiatry and Psychotherapy, University of Bern |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | University of Bern |
ClinicalTrials.gov Identifier: | NCT02505373 |
Other Study ID Numbers: |
144/08 |
First Posted: | July 22, 2015 Key Record Dates |
Last Update Posted: | January 14, 2016 |
Last Verified: | January 2016 |
Brief Therapy Attempted Suicide Therapeutic Alliance |
Suicidal Ideation Suicide ASSIP |
Suicide Suicidal Ideation Suicide, Attempted Self-Injurious Behavior Behavioral Symptoms |